CME Group falls 3.3% as investors appear to take profits; no clear company-specific catalyst

CME Group (CME) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: There does not appear to be a single, obvious piece of company-specific news driving the decline, so the move looks most consistent with profit-taking and a shift in expectations for near-term trading activity. This could be because implied volatility and rate-macro uncertainty can ebb and flow quickly, and CME’s revenue is closely tied to derivatives volume and market activity.

Details:

CME posted record first-quarter 2026 results, including record revenue and strong adjusted earnings per share, which can set a high bar for follow-through and sometimes leads to “sell-the-strength” trading.

The company reported April 2026 average daily volume of 25.9 million contracts, with interest-rate products the largest contributor, reinforcing how sensitive results can be to changes in rates volatility.

CME recently announced product expansion initiatives (including plans for a compute futures market tied to GPU benchmarks), but these longer-dated growth efforts may not impact near-term financials.

CME’s shareholder materials for its 2026 annual meeting have been filed with the SEC; routine governance filings can draw attention to capital return, compensation, and other items but are not typically major price catalysts.

Sources:

CME Group (press releases), U.S. SEC (EDGAR), StockAnalysis.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CME Insider Trading Activity

$CME insiders have traded $CME stock on the open market 17 times in the past 6 months. Of those trades, 4 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:

TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 4 sales selling 60,000 shares for an estimated $17,186,681.
DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 7,200 shares for an estimated $1,984,798.
HILDA HARRIS PIELL (Sr MD & Chief HR Officer) sold 5,753 shares for an estimated $1,752,536
KEN VROMAN (Chief Transformation Officer) sold 5,160 shares for an estimated $1,594,440
BRYAN T DURKIN sold 4,200 shares for an estimated $1,300,530
JONATHAN L MARCUS (Sr MD General Counsel) sold 3,291 shares for an estimated $1,097,120
WILLIAM R SHEPARD has made 4 purchases buying 1,732 shares for an estimated $510,109 and 0 sales.
ELIZABETH A COOK sold 1,000 shares for an estimated $320,000
DENNIS SUSKIND sold 748 shares for an estimated $224,400
MARTIN J GEPSMAN sold 300 shares for an estimated $91,770

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CME Hedge Fund Activity

We have seen 892 institutional investors add shares of $CME stock to their portfolio, and 802 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ALPHABET INC. added 3,484,020 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,041,547,779
CAPITAL RESEARCH GLOBAL INVESTORS added 2,272,083 shares (+213.9%) to their portfolio in Q1 2026, for an estimated $679,239,212
PRICE T ROWE ASSOCIATES INC /MD/ removed 2,074,465 shares (-30.1%) from their portfolio in Q1 2026, for an estimated $620,161,311
VICTORY CAPITAL MANAGEMENT INC added 1,807,491 shares (+746.4%) to their portfolio in Q4 2025, for an estimated $493,589,642
JPMORGAN CHASE & CO added 1,559,916 shares (+16.3%) to their portfolio in Q4 2025, for an estimated $425,981,861
BANK OF AMERICA CORP /DE/ added 1,130,587 shares (+39.1%) to their portfolio in Q1 2026, for an estimated $337,988,983
TWO SIGMA INVESTMENTS, LP added 1,111,993 shares (+2817.7%) to their portfolio in Q1 2026, for an estimated $332,430,307

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CME Congressional Stock Trading

Members of Congress have traded $CME stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 12/18.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CME Price Targets

Multiple analysts have issued price targets for $CME recently. We have seen 8 analysts offer price targets for $CME in the last 6 months, with a median target of $318.0.

Here are some recent targets:

Benjamin Budish from Barclays set a target price of $316.0 on 04/23/2026
Michael Cyprys from Morgan Stanley set a target price of $353.0 on 04/23/2026
Patrick Moley from Piper Sandler set a target price of $329.0 on 04/15/2026
Chris Allen from Keefe, Bruyette & Woods set a target price of $305.0 on 04/08/2026
Bill Katz from TD Cowen set a target price of $328.0 on 02/05/2026
Ashish Sabadra from RBC Capital set a target price of $302.0 on 02/05/2026
Kenneth Worthington from JP Morgan set a target price of $266.0 on 02/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.